AzTrials
AzTrials

White Spot Lesion of ToothPhase 3NCT04994314

White Spot Lesions Prevention During Orthodontic Fixed Appliance Treatment: a Randomized Clinical Trial

A Phase 3 study testing nCaF2 primer in people with White Spot Lesion of Tooth, run by University of Baghdad at 1 site in Iraq.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effectiveness of calcium fluoride nanoparticles containing orthodontic primer in preventing or decreasing the incidence WSLs over a period of 6 months in patients with fixed orthodontic appliances. Read more about this study

Who is it for?
Any age
Conditions the study is for
White Spot Lesion of Tooth
What is being tested?
nCaF2 primer
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
31 participants
Where
1 siteIraq
Study dates
15 Feb 2021to 15 Feb 2022
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients have
  • Fully erupted permanent teeth (regardless the third molar),
  • Indication to have orthodontic treatment without extraction
  • Fair or good oral hygiene before or after oral hygiene instruction

Who cannot join

  • Patients will be excluded if they had
  • Previous orthodontic treatment or extractions
  • Missing teeth
  • Active enamel caries determined by clinical examination
  • Patients with enamel hypoplasia, dental fluorosis or tetracycline pigmentation
  • Labial restorations
Show all 11Show fewer
  • Severe periodontal diseases determined according to PDI index by Sigurd P. Ramfjord (Ramfjord, 1967)
  • Craniofacial syndromes such as clefts
  • Xerostomia determined from clinical history of the patient
  • Severely rotated teeth (limiting the appearance of buccal surfaces)
  • Heavy smokers determined by accounting the number of cigarettes per day and time to the first cigarette of the day (Heatherton et al., 1989) .

Trial locations and contacts

1 site in 1 country.

Rawof R. Al Tuma, MSc contact

+9647901762894

raooftoma@yahoo.com

Yassir A. Yassir, PhD contact

+9647703919599

yassirkyassir@gmail.com

Iraq1 site, 1 recruiting
  • Almina dental clinics

    Karbala, 56001

    Rawof R. Al Tuma, Msc, +9647901762894, raooftoma@yahoo.com

    Hawraa Y. Yossif, Assisstant, +9647714147888, hawraayosif@yahoo.com

    Recruiting

Other trials in Iraq

About this study

Official title: Effect of Calcium Fluoride Nanoparticles in Prevention of Demineralization During Orthodontic Fixed Appliance Treatment: a Randomized Clinical Trial

The aim of this study is to evaluate the effectiveness of calcium fluoride nanoparticles containing orthodontic primer in preventing or decreasing the incidence WSLs over a period of 6 months in patients with fixed orthodontic appliances.

This study proposed to be double blinded, split mouth, randomized clinical trial, with equal randomization (1:1 allocation ratio).

Read the detailed description

The sample was selected and recruited from patients attending two centres (Orthodontic Department at Karbala Governmental Specialized Dental Center and Almina Dental Private Clinics/Karbala), but the bonding and follow up sessions were done in Almina Dental Private Clinics/Karbala. Patient recruitment was done according to specified inclusion and exclusion criteria.

Intervention procedure planned to be by bonding fixed orthodontic appliances to all patients. The four quadrants of the mouth will be divided into two groups (Group 1 and 2), with one group, the upper right and lower left quadrants bonded with nCaF2 resin, while the upper left and lower right quadrants bonded with control resin. For the other group, the reverse will be carried out. Then, by the use of a computer random number generator, the two groups will be randomly allocated, and each number in the random table will be given a study number in order to create the final Allocation Table for the participants in the study (which contained the study number and allocation group). the primary planned to be measured by DIAGNOdent Pen 2190 device to measure enamel demineralization objectively, while the secondary objective planned to be quantitative detection of Streptococcus mutans bacteria by using real-time PCR

Being tested
nCaF2 primer, Control primer
Keywords
white spot lesions, orthodontic primer, calcium fluoride nanoparticles

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • nCaF2 primerDrug

    Also called Orthodontic primer containing calcium fluoride nanoparticles

    Calcium fluoride nanoparticles was added to conventional orthodontic primers to develop bioactive primer. This primer was examined previously for its biological and physical properties

  • Control primerDrug

    Also called TransbondTM XT orthodontic primer

    Conventional orthodontic primer

Study groups in NCT04994314
Study groupRoleWhat they receive
orthodontic primer containing calcium fluoride nanoparticlesActive comparatorFixed appliance for ten maxillary teeth and the contralateral mandibular teeth will be bonded using orthodontic primer containing calcium fluoride nanoparticles
Receives: Drug: nCaF2 primer
Control primerPlacebo comparatorFixed appliance for ten maxillary teeth (contralateral to experimental ten side)and the contralateral mandibular teeth will be bonded using conventional primer (TransbondTM XT orthodontic primers (3M-Unitek, Monrovia, USA)
Receives: Drug: Control primer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DIAGNOdent Pen scores change

    assessing changes in the amount of enamel demineralization (DIAGNOdent Pen scores) between four time points:-

    1. baseline (before brackets bonding)
    2. after one month of brackets bonding
    3. after three months of brackets bonding
    4. after six months of brackets bonding

    Measured: Six months

Secondary outcomes (1)
  1. Streptococcus mutans load change

    Quantitative detection of streptococcus mutans load changes (using real time PCR) between four time points:-

    1. baseline (before brackets bonding)
    2. after one month of brackets bonding
    3. after three months of brackets bonding
    4. after six months of brackets bonding

    Measured: Six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2021
  2. Study start15 Feb 2021
  3. Primary completion16 Dec 2021 (estimated)
  4. Study completion15 Feb 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study planned to be split mouth study with equal randomization (1:1 allocation ratio)
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
31 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04994314
Sponsor's protocol ID
calcium fluoride nanoparticles
Status last verified
Aug 2021
First submitted
27 Jul 2021
Last updated
6 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Al Tuma RR, Yassir YA. Effect of calcium fluoride nanoparticles in prevention of demineralization during orthodontic fixed appliance treatment: a randomized clinical trial. Eur J Orthod. 2023 Mar 31;45(2):122-132. doi: 10.1093/ejo/cjac055.

    PubMed 36049047

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing nCaF2 primer in people with White Spot Lesion of Tooth, run by University of Baghdad at 1 site in Iraq.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rawof R. Al Tuma, MSc (+9647901762894, raooftoma@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DIAGNOdent Pen scores change (time frame: Six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04994314, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2021; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in